Magenta Lifecare Limited
listed
₹1.40LMin. investment
Magenta Lifecare Limited IPO Details
Issue size
₹7Cr
IPO type
SME
Price range
₹35.00 – ₹35.00
Listing date
12 Jun 2024
Lot size
4000 shares
RHP/DRHP
Read
Price range₹35.00 – ₹35.00
IPO type
SME
Lot size4000 shares
Issue size₹7Cr
RHP/DRHP
Read
Magenta Lifecare Limited Timeline
- Bid start5 Jun 2024
- Bid end7 Jun 2024
- Allotment7 Jun 2024
- Release of funds11 Jun 2024
- Demat transfer10 Jun 2024
- Listing12 Jun 2024
About Magenta Lifecare Limited
Incorporated in 2015, Magenta Lifecare Limited is a manufacturer of foam-based products such as mattresses and pillows which is marketed under the brand “Magenta” in India. The product offerings include a wide range of mattresses such as memory foam, latex based, bonded mattresses, pocketed spring etc. and pillows such as memory foam pillow, moulded memory foam pillow, moulded contour foam pillow etc. They believe that their success is attributable to the quality of products that they offer to their customers, spread across retail, hotels and institutions. Driven by innovation, they strive to introduce new and innovative products on a continuous basis with the help of their team. For instance, they have introduced green tea and bamboo charcoal based herbal mattress and pet bed mattresses in their range of products. Further, they also supply processed raw foam and adjustable bed frame (hydraulic bed) which we import under our brand Magenta.
The company believes that their product offering is across the section of the society from value-added product to premium segment. Their thoughtfully-designed products provide comfort, with ergonomic design, thermal comfort, pressure relief, motion isolation, easy position realignment, and long-term durability. The products are designed to support, comfort, and cool the body, leading to better-quality sleep. They offer mattresses with diverse customization options in terms of fabric, shape, firmness, material, height, foam type & density, personalization, utility and structure.
They have developed distributor and dealer/retailer networks across multiple states in India. The products are sold from their offline channel of multi brand outlets and through a network of dealers and e-commerce platforms.
The company is capable of manufacturing both standardised as well as customised products. The manufacturing facility is located at Vadodara, Gujarat, India. The company’s current capacity for manufacturing mattresses is at 60,000 Nos. and 70,000 nos. of pillows. They benefit from the industry experience and business acumen of their individual Promoters, and are driven by their expertise. Their professional and experienced management team has been critical in building the brands, growing their operations and maintaining capital efficiency despite they emphasis on affordable product offerings. Under their leadership the company have been able to expand its operations and have established a significant presence in India. As on date of Prospectus , our overall staff strength is 41 employees including skilled and unskilled labour.
Magenta Lifecare Limited Prepares for its Initial Public Offering (IPO), the proceeds generated from the Fresh Issue will be allocated towards crucial objectives:
- Funding our working capital requirements; and
- General corporate purposes
Checklist
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial
health at a glance and identify quality investment opportunities easily
Magenta Lifecare Limited Contact Details
Company NameMagenta Lifecare Limited
How to apply for Magenta Lifecare Limited?
- Step 1
Log in to your Upstox account to access IPO investments. Next, select the current IPO section.
- Step 2
Specify IPO details. Enter the number of lots and the price you wish to apply for.
- Step 3
Enter UPI ID. After entering your UPI ID, click submit. This will place your bid with the exchange.
- Step 4
Mandate Notification. Your UPI app will receive a mandate notification to block funds.
- Step 5
Approve Request. Your funds will be blocked once you approve the mandate request on your UPI.
Magenta Lifecare IPO FAQs
How to invest in the Magenta Lifecare Limited ?
Investors can apply for the Magenta Lifecare Limited through their Demat account via the stock exchange or through their broker.
What is the issue size of Magenta Lifecare Limited ?
The issue size of the Magenta Lifecare Limited is 7 Cr.
What is 'pre-apply' for Magenta Lifecare Limited ?
Pre-applying for an IPO allows you to submit your application before the official subscription period begins.
Which exchanges will Magenta Lifecare Limited shares list on?
The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.
What are the open and close dates of the Magenta Lifecare Limited ?
Magenta Lifecare Limited will be open between 2024-06-05 and 2024-06-07.
What is the allotment date for the Magenta Lifecare Limited ?
Magenta Lifecare Limited allotment date is 2024-06-10. For Magenta Lifecare Limited allotment status check, you can visit the website of the registrar of the IPO.
Who is the registrar of Magenta Lifecare Limited ?
For Magenta Lifecare Limited, the IPO registrar is Cameo Corporate Services Limited. You can check Magenta Lifecare Limited allotment status on the website of the registrar.
Where is the Magenta Lifecare Limited getting listed?
The shares are proposed to be listed on the BSE and NSE.
When will Magenta Lifecare Limited shares be credited to your demat account?
The Magenta Lifecare Limited shares will typically be credited to your demat account one working day before the IPO's listing date, provided your application is successfully allotted.
What is the lot size and minimum order quantity of the Magenta Lifecare Limited ?
The Magenta Lifecare Limited lot size is 4000 and minimum order quantity is 4000.
What is the price band for the Magenta Lifecare Limited ?
Magenta Lifecare Limited has set the price band for its IPO at 35 per equity share with a face value of 10.